Latus Bio Funding & Investors
Philadelphia, PA
Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing.
latusbio.comTotal Amount Raised: $54,000,000
Latus Bio Funding Rounds
Series A
$54,000,000
Series A Investors
8VCDCVCSamsung Life Science FundGaingelsModi VenturesChildren's Hospital of Philadelphia (CHOP)Ben Franklin Technology Partners
Funding info provided by Diffbot.